Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide study.

Zhen-Hua ChenXiu-Ping ZhangYu-Gang LuLe-Qun LiMin-Shan ChenTian-Fu WenWei-Dong JiaDong ZhouJing LiDing-Hua YangZuo-Jun ZhenYi-Jun XiaRui-Fang FanYang-Qing HuangYu ZhangXiao-Jing WuYi-Ren HuYu-Fu TangJian-Hua LinFan ZhangCheng-Qian ZhongWei-Xing GuoJie ShiJoseph LauShu-Qun Cheng

Published in: Hepatology international (2020)

One in nine HCC patients with PVTT reached the long-term survival milestone of 3 years after resection. Major hepatectomy, controlling intraoperative blood loss, R0 resection, adjuvant TACE, and 'curative' treatment for initial recurrence should be considered for patients to achieve better long-term survival outcomes.

Keyphrases

end stage renal disease
prognostic factors
ejection fraction
newly diagnosed
chronic kidney disease
early stage
patient reported outcomes